scholarly article | Q13442814 |
P50 | author | Michael Pawlita | Q37242255 |
Tim Waterboer | Q66386567 | ||
Peter J F Snijders | Q90768556 | ||
P2093 | author name string | Markus Schmitt | |
Lutz Gissmann | |||
I G Bravo | |||
P2860 | cites work | The causal relation between human papillomavirus and cervical cancer | Q24673148 |
T-Coffee: A novel method for fast and accurate multiple sequence alignment | Q27860999 | ||
Papillomaviruses and cancer: from basic studies to clinical application | Q29614745 | ||
Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women | Q30917882 | ||
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method | Q33679334 | ||
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes | Q33950978 | ||
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus | Q33961947 | ||
Improved amplification of genital human papillomaviruses | Q33974896 | ||
Cancer burden in the year 2000. The global picture | Q34402117 | ||
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality | Q35154918 | ||
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays | Q35789859 | ||
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings | Q36543787 | ||
Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse | Q40421829 | ||
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. | Q43515341 | ||
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins | Q46650085 | ||
Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system | Q50104507 | ||
Microsphere suspension array technology for SNP detection in cattle | Q51818939 | ||
Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. | Q52963160 | ||
New cervical cancer screening strategy: combined Pap and HPV testing. | Q53359912 | ||
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR | Q73108013 | ||
Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification | Q73734970 | ||
Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping | Q73777223 | ||
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer | Q80373798 | ||
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | genotyping | Q912147 |
P304 | page(s) | 504-512 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Bead-based multiplex genotyping of human papillomaviruses | |
P478 | volume | 44 |
Q27332306 | A bead-based multiplex assay for the detection of DNA viruses infecting laboratory rodents |
Q64053966 | A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin |
Q43060170 | A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples |
Q86832615 | A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma |
Q100634459 | ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers |
Q33614132 | Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay |
Q37263655 | Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins |
Q33330059 | Advances in multiple analyte profiling. |
Q90629815 | An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway |
Q93125739 | Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay |
Q38859268 | Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls |
Q38859265 | Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer |
Q43308250 | Are human papillomavirus DNA prevalences providing high-flying estimates of infection? An international survey of HPV detection on environmental surfaces |
Q34806026 | Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease. |
Q35691927 | Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil |
Q37838503 | Asymptomatic anal sexually transmitted infections in HIV-positive men attending anal cancer screening |
Q35273769 | Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types. |
Q40175186 | Bead-based suspension array for simultaneous differential detection of five major swine viruses |
Q92090103 | Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses |
Q55279812 | Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants. |
Q53081710 | Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. |
Q37003406 | Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. |
Q36295974 | Biomarkers of HPV in head and neck squamous cell carcinoma. |
Q40873298 | CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma |
Q35985028 | Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin |
Q35984742 | Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma |
Q36813303 | Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens |
Q64069837 | Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine |
Q36584383 | Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update |
Q37582845 | Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses |
Q48134092 | Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression |
Q94585060 | Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening |
Q37643509 | Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region |
Q37800921 | Commercially available assays for multiplex detection of alpha human papillomaviruses |
Q41027688 | Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). |
Q37546224 | Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping |
Q36413963 | Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. |
Q42246317 | Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma |
Q40122573 | Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study |
Q38674506 | Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens. |
Q93233995 | Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma |
Q84155467 | Creation and characterization of a xenograft model for human cervical cancer |
Q30276138 | Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study |
Q30409315 | Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study |
Q27693832 | Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? |
Q57148320 | Cutaneous viral infections across two anatomic sites among a cohort of skin cancer screening patients |
Q35689066 | Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study |
Q34212228 | Detection of human papillomaviruses by polymerase chain reaction and ligation reaction on universal microarray |
Q38658091 | Detection of oncogenic viruses in water environments by a Luminex-based multiplex platform for high throughput screening of infectious agents |
Q37116707 | Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses |
Q34185819 | Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection |
Q39882377 | Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes |
Q35193233 | Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies |
Q27485492 | Diagnostic Evaluation of Multiplexed Reverse Transcription-PCR Microsphere Array Assay for Detection of Foot-and-Mouth and Look-Alike Disease Viruses |
Q40280339 | Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study. |
Q64061838 | Distribution of high-risk HPV types among women in Sichuan province, China: a cross-sectional study |
Q40681570 | Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study. |
Q42256779 | Diversity of human papillomaviruses in skin lesions |
Q41864212 | Dramatic increase in the signal and sensitivity of detection via self-assembly of branched DNA |
Q38959371 | Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents |
Q53519290 | Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma. |
Q37628138 | Emerging molecular assays for detection and characterization of respiratory viruses |
Q38944279 | Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice |
Q51553909 | Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods |
Q35083596 | Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples |
Q35192200 | Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts. |
Q37348338 | Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma |
Q34782761 | Expressed prostate secretions in the study of human papillomavirus epidemiology in the male |
Q34472748 | Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma |
Q38879048 | Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study. |
Q40651861 | FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women |
Q37845965 | False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection |
Q34411111 | Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2) |
Q51490957 | Flow field induced particle accumulation inside droplets in rectangular channels. |
Q40500436 | Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable |
Q35267714 | Food microbial pathogen detection and analysis using DNA microarray technologies |
Q40172590 | Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study |
Q34046478 | Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study |
Q34542473 | Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study |
Q38874178 | Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer |
Q40892448 | German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment |
Q34489632 | Global Proficiency Study of Human Papillomavirus Genotyping |
Q37546177 | Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study |
Q59330336 | Gynecologic assessment of 19 adult females with cartilage-hair hypoplasia - high rate of HPV positivity |
Q36238070 | HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization. |
Q36088064 | HPV detection methods in head and neck cancer |
Q34345540 | HPV genotyping and site of viral integration in cervical cancers in Indian women |
Q51653476 | HPV infection among women in a representative rural and suburban population of the USA. |
Q42377376 | HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors? |
Q58574765 | HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV |
Q35133590 | Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome |
Q34493325 | High expression of ezrin predicts poor prognosis in uterine cervical cancer |
Q38800101 | High prevalence of human papillomaviruses in Ghanaian pregnant women |
Q44794336 | High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort |
Q34806867 | High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients |
Q36381319 | High-throughput SNP-based authentication of human cell lines |
Q37393485 | High-throughput detection and multiplex identification of cell contaminations |
Q35101247 | Highly Sensitive Detection and Genotyping of HPV by PCR Multiplex and Luminex Technology in a Cohort of Colombian Women with Abnormal Cytology |
Q36497937 | Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers |
Q36197117 | Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings |
Q36418117 | Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013. |
Q37923517 | Human papilloma virus (HPV) molecular diagnostics. |
Q41579102 | Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes |
Q47260023 | Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence |
Q39145678 | Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study |
Q42217974 | Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy |
Q47790765 | Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study. |
Q33778119 | Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review). |
Q37703394 | Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome |
Q45084618 | Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study |
Q35232819 | Human papillomavirus and tonsillar and base of tongue cancer |
Q40214883 | Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer. |
Q42276676 | Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials |
Q51426652 | Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. |
Q92585076 | Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status |
Q42244723 | Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India |
Q28286766 | Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor |
Q43777296 | Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study |
Q92462451 | Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study |
Q47599112 | Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts. |
Q40292220 | Human papillomavirus prevalence in mouthwashes of patients undergoing tonsillectomy shows dominance of HPV69, without the corresponding finding in the tonsils |
Q36706422 | Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma |
Q35050431 | Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women |
Q64262922 | Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention |
Q37650660 | Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina |
Q42274810 | Human papillomavirus-associated balanoposthitis--a marker for penile intraepithelial neoplasia? |
Q34544410 | Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma |
Q58813676 | Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway |
Q33940157 | Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study |
Q45942793 | Increasing hybridization rate and sensitivity of bead-based assays using isotachophoresis. |
Q43564259 | Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. |
Q34600215 | Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis |
Q33682928 | Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types |
Q38739835 | Isolation and characterization of a novel putative human polyomavirus |
Q40258689 | Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer |
Q36755552 | LUMINEX®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools |
Q36414507 | Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas |
Q42204957 | Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. |
Q38867836 | Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma |
Q47599117 | Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy |
Q36281407 | Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines. |
Q42200739 | Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. |
Q37116753 | Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus |
Q39120200 | Molecular approaches for HPV genotyping and HPV-DNA physical status |
Q33428795 | Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen |
Q39400513 | Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas. |
Q39725202 | Multiplatform comparison of multiplexed bead arrays using HPV genotyping as a test case. |
Q36826745 | Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities |
Q41689179 | Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples. |
Q54305915 | Multiplex analysis of tumor multidrug-resistance genes expression with photonic suspension array. |
Q36398321 | Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array. |
Q88113305 | Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer |
Q34447373 | Natural history of polyomaviruses in men: the HPV infection in men (HIM) study. |
Q45338163 | Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. |
Q42263135 | No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors |
Q59353927 | Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests |
Q35689082 | Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types |
Q54335305 | Novel multiplexed genotyping of human papillomavirus using a VeraCode-allele-specific primer extension method. |
Q38826857 | Oral health and human papillomavirus-associated head and neck squamous cell carcinoma |
Q42275766 | Oral human papillomavirus prevalence in high school students of one municipality in Sweden. |
Q35804927 | Oropharyngeal Cancer Epidemic and Human Papillomavirus |
Q42204969 | Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer |
Q43691500 | Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment. |
Q43117756 | Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses |
Q41744901 | Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus. |
Q51580698 | Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. |
Q54946451 | Polyomaviruses detectable in head and neck carcinomas. |
Q41119047 | Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland |
Q34916951 | Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. |
Q35498040 | Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities |
Q40847705 | Presence of human papillomavirus in semen in relation to semen quality |
Q44817366 | Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer |
Q36253884 | Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy. |
Q33629489 | Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples |
Q41206464 | Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India |
Q58585929 | Prevalence and correlates of beta and gamma human papillomavirus detection in oral samples from mid-adult women |
Q55082939 | Prevalence and correlates of beta human papillomavirus detection in fingernail samples from mid-adult women. |
Q54289295 | Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. |
Q39841008 | Prevalence of BPV genotypes in a German cowshed determined by a novel multiplex BPV genotyping assay |
Q38673356 | Prevalence of cutaneous beta and gamma human papillomaviruses in the anal canal of men who have sex with women. |
Q34450371 | Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour |
Q51023169 | Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination. |
Q92579765 | Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia |
Q44457555 | Prevalence of human papillomavirus types in cervical and oral cancers in central India |
Q52585506 | Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer. |
Q36221266 | Prevalence of oral human papillomavirus infection among youth, Sweden |
Q34640608 | Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors |
Q34404710 | Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study |
Q34518220 | Previous tonsillectomy modifies odds of tonsil and base of tongue cancer |
Q37154221 | Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts |
Q33854472 | Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma |
Q31149498 | Quantitative data analysis methods for bead-based DNA hybridization assays using generic flow cytometry platforms. |
Q53071357 | Radiotherapy response in head and neck cancer - evaluation of the primary tumour site. |
Q35066941 | Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques |
Q35847330 | Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories |
Q40289265 | Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma |
Q42270386 | Smoking increases oral HPV persistence among men: 7-year follow-up study |
Q42238481 | Stable marital relationship protects men from oral and genital HPV infections |
Q87423605 | Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery |
Q90238817 | Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway |
Q61444373 | TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration |
Q36118729 | The 2010 global proficiency study of human papillomavirus genotyping in vaccinology |
Q33702362 | The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma |
Q40349414 | The male ScreenING Study: prevalence of HPV-related genital and anal lesions in an urban cohort of HIV-positive men in Germany |
Q40291505 | The prevalence of HPV infections in HPV-vaccinated women from the general population. |
Q92445348 | The use of molecular markers for cervical screening of women living with HIV in South Africa |
Q33517490 | Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples |
Q37352574 | Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland |
Q38133612 | Understanding HPV tests and their appropriate applications |
Q47748258 | Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma. |
Q36513003 | Using oligonucleotide suspension arrays for laboratory identification of bacteria responsible for bacteremia |
Q35113813 | Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes |
Q37360505 | Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples |
Q36852263 | Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women |
Q41020481 | Viral infections in prostate carcinomas in Chilean patients |
Q41203108 | Viral load and mRNA expression of HPV type 6 among cases with recurrent respiratory papillomatosis |
Q40070529 | Viruses in cancers among the immunosuppressed. |
Q38967902 | p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region |
Q40767169 | p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population |